Zigao Yuan
Impact in
- Oncology top 10%
- PARP inhibition in cancer therapy
- Peptidase Inhibition and Analysis
-
- Histone Deacetylase Inhibitors Research
- Protein Degradation and Inhibitors
- Epigenetics and DNA Methylation
- Cancer therapeutics and mechanisms
- Ubiquitin and proteasome pathways
Papers in
-
- Protein Degradation and Inhibitors 10
- Histone Deacetylase Inhibitors Research 10
- Epigenetics and DNA Methylation 8
- Cancer therapeutics and mechanisms 6
- Oncology 11
- PARP inhibition in cancer therapy 6
- Cancer Immunotherapy and Biomarkers 2
- Co-authors
- Yuyang Jiang (19 shared papers)Chunmei Gao (13 shared papers)Qinsheng Sun (10 shared papers)Qiuzi Dai (10 shared papers)Yu Chen (5 shared papers)Shaopeng Chen (5 shared papers)Yuyang Jiang (6 shared papers)Cunlong Zhang (9 shared papers)
In The Last Decade
Zigao Yuan
28 papers receiving 724 citations
Peers
Comparison fields: 5 of 76
- Oncology 210
- Molecular Biology 499
- Toxicology 18
- Organic Chemistry 133
- Bioengineering 20
Countries citing papers authored by Zigao Yuan
This map shows the geographic impact of Zigao Yuan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zigao Yuan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zigao Yuan more than expected).
Fields of papers citing papers by Zigao Yuan
This network shows the impact of papers produced by Zigao Yuan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zigao Yuan. The network helps show where Zigao Yuan may publish in the future.
Co-authors
The 25 scholars most cited alongside Zigao Yuan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 30 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 83 | |
| 2 | 2017 | 76 | |
| 3 | 2017 | 61 | |
| 4 | 2017 | 50 | |
| 5 | 2019 | 48 | |
| 6 | 2018 | 44 | |
| 7 | 2024 | 39 | |
| 8 | 2017 | 39 | |
| 9 | 2017 | 37 | |
| 10 | 2024 | 25 | |
| 11 | 2019 | 24 | |
| 12 | 2016 | 20 | |
| 13 | 2024 | 20 | |
| 14 | 2021 | 20 | |
| 15 | 2019 | 20 | |
| 16 | 2021 | 18 | |
| 17 | 2017 | 16 | |
| 18 | 2024 | 16 | |
| 19 | 2019 | 14 | |
| 20 | 2018 | 13 |
About Zigao Yuan
Zigao Yuan is a scholar working on Molecular Biology, Oncology, Organic Chemistry, Immunology and Pathology and Forensic Medicine, having authored 30 papers that have together received 732 indexed citations. Recurring topics across this work include Protein Degradation and Inhibitors (10 papers), Histone Deacetylase Inhibitors Research (10 papers), Epigenetics and DNA Methylation (8 papers), PARP inhibition in cancer therapy (6 papers), Cancer therapeutics and mechanisms (6 papers), Molecular Sensors and Ion Detection (2 papers), interferon and immune responses (2 papers) and Cancer Immunotherapy and Biomarkers (2 papers). The work is most often cited by research in Oncology (210 citations), Molecular Biology (499 citations), Toxicology (18 citations), Organic Chemistry (133 citations) and Bioengineering (20 citations). Zigao Yuan has collaborated with scholars based in China, Singapore and Hong Kong. Frequent co-authors include Yuyang Jiang, Chunmei Gao, Qinsheng Sun, Qiuzi Dai, Yu Chen, Shaopeng Chen, Yuyang Jiang, Cunlong Zhang, Lei Zhao and Chunyan Tan. Their work appears in journals such as European Journal of Medicinal Chemistry, Chinese Chemical Letters, Bioorganic & Medicinal Chemistry, Bioorganic & Medicinal Chemistry Letters and Cell Death Discovery.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.